<DOC>
	<DOCNO>NCT00646971</DOCNO>
	<brief_summary>Patients sleep apnea syndrome repeat apneic event induce periodic hypoxia-reoxygenation , draw away overproduction oxidant . This exaggerated generation oxidant associate dysfunction vascular endothelium evolves , turn , towards cardiovascular disease systemic hypertension , stroke , myocardial infarction . The major aim study examine effect CPAP treatment biochemical ( marker oxidative stress ) functional ( endothelium-dependent vascular relaxation reactivity ) abnormalities 1 4 week treatment .</brief_summary>
	<brief_title>Oxidative Stress Endothelial Dysfunction Obstructive Sleep Apnea</brief_title>
	<detailed_description>Subjects undergo overnight polysomnography sleep laboratory ( PSG1 , D0 ) , immediately precede followed measurement oxidative stress exhale gas vascular relaxation . Patients include OSAS group randomly assign treatment either CPAP Placebo ( sham CPAP ) 4 week . Measurements oxidative stress exhale gas vascular reactivity repeat immediately PSG2 PSG3 D7 D30 , respectively .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Anoxia</mesh_term>
	<criteria>No smoking 3070 year old subject refer daytime hyper somnolence snore apnea hypopnea index &gt; =30/hour desaturation index &gt; =30/hour Chronic lung disease . Exposure occupational contaminant . Active smoking within last 2 year . Alcoholism . Chronic systemic disease OSAS . Treatment vasoactive drug antioxidant Respiratory infection vaccination 6 week precede PSG1 .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Isoprostane</keyword>
	<keyword>Alkane</keyword>
	<keyword>Exhaled condensate</keyword>
	<keyword>Peripheral arterial tonometry</keyword>
	<keyword>Polysomnography</keyword>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Hypoxia</keyword>
</DOC>